Active Ingredient History

  • Now
Narnatumab is a human monoclonal antibody designed for the treatment of cancer. Clinical development was abandoned after phase I trials.   Wikipedia

More Chemistry
imc-ron8 | imc-ron-8 | narnatumab | ron8


Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue